Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,723,498 papers from all fields of science
Search
Sign In
Create Free Account
Antipyrine / Benzocaine
Known as:
antipyrine benzocaine
, ANTIPYRINE/BENZOCAINE
, antipyrine-benzocaine
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Antipyrine
Benzocaine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
14C-antipyrine as a model compound in the study of drug oxidation and enzyme induction in individual surviving rats.
O. Bakke
,
M. Bending
,
J. Aarbakke
,
D. Davies
Acta Pharmacologica et Toxicologica
2009
Corpus ID: 27712861
A rapid method for the estimation of antipyrine-N-methyl-14C in small samples of whole blood has been developed. A study of the…
Expand
1983
1983
Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine.
M. Eichelbaum
,
L. Bertilsson
,
J. Säwe
British Journal of Clinical Pharmacology
1983
Corpus ID: 20342365
Thirty-five healthy subjects who had been classified as extensive or poor metabolizers of both sparteine and debrisoquine were…
Expand
Highly Cited
1982
Highly Cited
1982
Differential effects of enzyme induction on antipyrine metabolite formation.
M. Danhof
,
R. Verbeek
,
C. Boxtel
,
JK Boeijinga
,
D. Breimer
British Journal of Clinical Pharmacology
1982
Corpus ID: 35107288
1 The influence of enzyme induction with antipyrine and pentobarbitone was studied on the rates of formation of the major…
Expand
1982
1982
3-Hydroxymethyl antipyrine excretion in urine after an oral dose of antipyrine. A reconsideration of previously published data and synthesis of a pure reference substance.
M. Danhof
,
M. Teunissen
,
D. Breimer
Pharmacology
1982
Corpus ID: 46869927
Previously published data from this laboratory on the urinary excretion of 3-hydroxymethyl antipyrine (one of the major…
Expand
1982
1982
Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration.
M. Eichelbaum
,
H. Ochs
,
G. Roberts
,
A. Somogyi
Arzneimittel-Forschung
1982
Corpus ID: 35961775
To 12 healthy male volunteers, 6 smokers and 6 non-smokers, 10 mg/kg antipyrine (phenazone) was administered i.v. and p.o. in…
Expand
1981
1981
Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation.
M. Danhof
,
J. Idle
,
M. Teunissen
,
T. Sloan
,
D. Breimer
,
R. Smith
Pharmacology
1981
Corpus ID: 46771871
The influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation was…
Expand
1980
1980
Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery.
N. Buchanan
,
M. Davis
,
M. Danhof
,
D. Breimer
British Journal of Clinical Pharmacology
1980
Corpus ID: 2443784
1. The plasma elimination rate of antipyrine and the urinary excretion of antipyrine and its primary metabolites 4-hydroxy…
Expand
1975
1975
Vascular resistance in peripheral blood vessels at normotension and at local orthostatic hypertension in healty humans.
W. Paaske
,
O. Henriksen
Acta Physiologica Scandinavica
1975
Corpus ID: 46702358
The effect of changes in orthostatic pressure on vascular resistance in subcutaneous adipose tissue was examined in the forearm…
Expand
1965
1965
Drug absorption and exsorption kinetics in goldfish.
G. Levy
,
K. E. Miller
Journal of Pharmacy and Science
1965
Corpus ID: 36216650
The utility of goldfish as test animals for studies of biologic membrane permeation has led to a detailed analysis of the…
Expand
1955
1955
A comparison of the volume of distribution of antipyrine, N-acetyl-4-amino-antipyrine, and I131-labeled 4-iodo-antipyrine in human beings.
P. Talso
,
T. Lahr
,
N. Spafford
,
G. Ferenzi
,
H. R. Jackson
Journal of Laboratory and Clinical Medicine
1955
Corpus ID: 8914771